Trials / Completed
CompletedNCT05506098
Investigating STAT3 as a Driver of Pathology in Periodontitis
Investigating STAT3 as a Driver of Pathology and Potential Therapeutic Target in Periodontitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (actual)
- Sponsor
- University of Chile · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Periodontitis is a prevalent inflammatory condition that destroys tooth-supporting structures. This condition is associated with pro-inflammatory mediators that utilize STAT3 as an activator of specific genes related to inflammation and tissue destruction. STAT3 has not been studied in the context of periodontitis in humans. We propose that STAT3 is associated with periodontitis. This knowledge might help to further our understanding of periodontitis pathology
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention | no intervention |
Timeline
- Start date
- 2019-03-20
- Primary completion
- 2022-10-20
- Completion
- 2022-10-20
- First posted
- 2022-08-18
- Last updated
- 2023-01-30
Locations
1 site across 1 country: Chile
Source: ClinicalTrials.gov record NCT05506098. Inclusion in this directory is not an endorsement.